Traditional systemic drug administration methods remain plagued by a high incidence of unintended side effects. These adverse outcomes, often resulting from drugs interacting with healthy tissues, contribute significantly to clinical trial failures, underscoring the pressing need for novel approaches capable of achieving pinpoint accuracy in drug delivery. Building upon emerging advances in nanotechnology, materials science, and biomedical engineering, the latest research harnesses tiny, wireless microrobots whose precise movements within the body’s labyrinthine environments are controlled magnetically.

The team, led by Fabian Landers and collaborators, introduces a modular platform integrating a sophisticated electromagnetic navigation system dubbed Navion with an engineered release catheter and a drug-loaded, dissolvable gelatin capsule. These microrobots, composed primarily of biocompatible, biodegradable gelatin embedded with magnetic and radiopaque nanoparticles, allow real-time tracking via X-ray imaging while simultaneously ferrying therapeutic payloads. This integration of locomotion, navigation, imaging, and controlled drug release into a single system marks a pivotal step toward clinical viability.

Unlike tethered devices, these microrobots operate untethered, enabling maneuverability through intricate vascular networks including the cerebral vasculature and cerebrospinal fluid spaces. Through strategic application of magnetic fields generated by the Navion system, the microrobots can be guided over tremendous distances relative to their size, negotiating sharp turns and bifurcations with remarkable dexterity. This precise control facilitates access to even the smallest and most elusive blood vessels, historically inaccessible to previously existing drug delivery modalities.

Importantly, once the microrobot reaches the target site, the release mechanism kicks in through localized, controlled heating. This heat stimulus triggers the dissolution of the gelatin capsule, thereby releasing the encapsulated drugs directly into the targeted tissue microenvironment. The capsule’s biodegradable nature ensures that no permanent foreign material remains post-delivery, significantly reducing the risk of long-term complications arising from device implantation.

To validate their platform, Landers et al. conducted extensive in vitro experiments using human vascular models that mimic the anatomical and physiological characteristics of human blood vessels. These experiments demonstrated not only navigational precision but also effective, targeted drug release confined to intended sites. Extending their proof of concept, the researchers further tested their system in vivo with large animal models, including sheep and pigs, under conditions that closely replicate human clinical settings.

Remarkably, the in vivo trials underscored the system’s potential in real-world applications. The microrobots successfully traversed the complex biological terrain, navigating through natural fluid flows and anatomical constraints without invasive surgical intervention. Additionally, controlled dissolution and drug release at prescribed locations were achieved without adverse physiological reactions, highlighting the platform’s safety and efficacy potential.

The research does not exist in isolation. Prior studies referenced by the team illustrate complementary advances, including the use of magnetic microrobots for treating infections deep within sinus cavities and employing ultrasound combined with magnetic controls to manipulate microrobots for targeted therapy. Such interdisciplinary synergies bolster the prospects for widespread adoption of microrobotic technologies in diverse medical applications.

Despite these achievements, the authors acknowledge significant hurdles remain on the path toward full clinical translation. Challenges lie in ensuring biocompatibility across variable patient physiologies, scaling manufacturing processes for consistent quality, refining imaging integration for seamless operation, and navigating the complex regulatory landscape governing medical devices. Nonetheless, the presented framework offers a robust foundation and direction for ongoing innovation.

The implications of this breakthrough extend far beyond drug delivery for vascular diseases. The ability to traverse anatomically complex and sensitive regions of the body non-invasively opens avenues for therapies in neurology, oncology, and infectious diseases, where precise dosing and minimal collateral damage are paramount. Furthermore, the modularity and programmability of the magnetic guidance system offer adaptability to multifarious therapeutic agents, including bioactive molecules and gene-editing tools.

In summary, the development of clinically ready magnetic microrobots integrating electromagnetic navigation, real-time imaging, and biocompatible drug release mechanisms promises to revolutionize targeted medical therapies. By converging multidisciplinary expertise across engineering, physics, and medicine, the technology embodies the future of minimally invasive precision medicine. Continued refinement and clinical testing hold the key to transforming these small marvels into everyday therapeutic workhorses.

Fabian Landers and colleagues’ contribution epitomizes the forefront of bio-robotics applied to health care. Their work energizes a dynamic field seeking to mitigate the perennial problems of systemic drug toxicity while enhancing therapeutic outcomes. As these magnetically guided microrobots edge closer to clinical application, patients and healthcare providers alike may soon witness a new era of precision-targeted treatment.

Subject of Research: Magnetically guided microrobotics for targeted drug delivery in complex biological environments.

Article Title: Clinically ready magnetic microrobots for targeted therapies

News Publication Date: 13-Nov-2025

Web References:
DOI: 10.1126/science.adx1708

Keywords: Magnetic microrobots, targeted drug delivery, electromagnetic navigation, biodegradable capsules, vascular navigation, precision medicine, real-time X-ray imaging, minimally invasive therapy, gelatin-based microrobots, drug release control, in vivo validation, bio-robotics

Ultrasound devices are integral to numerous medical applications, from diagnosing ailments in clinical settings to facilitating remote care in telemedicine. However, the prevalent use of lead in many commercial ultrasound transducers poses significant health and environmental risks. These concerns have catalyzed the search for safer, more efficient alternatives that marry high performance with ecological responsibility. The evolving landscape of medical technology is demanding shifts toward sustainable innovations, and this latest silicon nanocolumn-based approach answers that call.

By employing innovative semiconductor manufacturing techniques, the research team has created an ultrathin patch that measures just a few hundred micrometers thick. The craftsmanship involved in transforming silicon into a nanocolumn structure has proven to be vital in achieving a device that is not only thin and flexible but also delivers enhanced performance metrics. With this new ultrasound patch, the researchers successfully eliminated the traditional matching and backing layers that are standard components in most standard piezoelectric transducers. This radical design reimagines the ultrasound patch, ensuring that it provides stable performance without the need for lead.

In rigorous experimental validations, the newly developed patch displayed remarkable capabilities. It achieved over a 30% increase in output pressure compared to conventional transducers, translating into significantly higher image quality during diagnostic processes. Moreover, this advanced patch has shown the ability to accurately measure blood flow velocity and vessel diameter in dynamic areas, such as the neck, which can be notoriously challenging due to patient movement or variability in anatomical positioning. Through these developments, it has also been established that the patch can achieve over 96% accuracy when matched against clinical blood pressure monitors, solidifying its clinical viability.

The implications of this silicon-based innovation are far-reaching, especially in the realms of personalized healthcare and telemedicine. As the global healthcare framework increasingly integrates remote monitoring capabilities, the demand for high-quality and accurate but easy-to-use medical equipment is rapidly escalating. The researchers anticipate that their silicon ultrasound patch will not only meet this demand but will do so in a cost-effective manner. The estimated production cost of their device is approximately 1/20th of that of existing lead-based counterparts, making it an economically attractive solution as well.

Another critical advantage of the silicon ultrasound patches is their reduced environmental impact. Traditional ultrasound devices pose a disposal challenge given the toxic nature of lead. In contrast, the creation and subsequent disposal of these silicon patches present a much lower ecological footprint, aligning with global sustainability goals. The ability to mass-produce these patches through semiconductor processes enhances their practicality, promising easy accessibility and widespread use across various medical fields, including cardiovascular health, rehabilitation, and mental health monitoring.

As the research continues, the authors also plan to conduct further explorations into the safety and reliability of this new technology in diverse clinical settings, aspiring to address various medical needs. This robust exploration shows a commitment not only to advancing technology but also to providing comprehensive health solutions that can universally benefit patients. Dr. Byung Chul Lee’s assertion about the meaningfulness of this work emphasizes a collective ambition within the research community to prioritize human safety while advancing scientific frontiers.

Experts such as Prof. Whal Lee from Seoul National University Hospital have highlighted the practical benefits of these silicon-based devices, noting their flexibility and adaptability in design. This adaptability further widens the spectrum of medical applications for ultrasound imaging, enhancing the potential to serve patients in unique, innovative formats that accommodate a broader range of healthcare needs.

In conclusion, this silicon-based ultrasound patch signifies a monumental leap toward safer, more effective ultrasound technology. The innovative approach to eliminating lead while enhancing diagnostic capabilities highlights the intersection of engineering, healthcare, and environmental responsibility. It showcases a future where medical devices not only serve their primary functions but do so with minimal health risks and maximal efficiency. As the medical community embraces these advancements, it is evident that the landscape of patient care will be fundamentally transformed.

The implications of this breakthrough extend beyond immediate applications. As additional research emerges and as clinical trials progress, the integration of this silicon-based technology into everyday medical practices may also enable earlier detection of diseases, better monitoring of patient conditions, and personalized medical interventions that cater specifically to individual health journeys. This innovative approach could ultimately redefine the standard for ultrasound technology, ensuring that safety, efficiency, and environmental sustainability go hand in hand. The future of ultrasound imaging looks brighter now, thanks to brilliant minds devoted to harnessing technology for the greater good.

Subject of Research: Silicon-based disposable ultrasound patches
Article Title: Silicon nanocolumn-based disposable and flexible ultrasound patches
News Publication Date: 18-Jul-2025
Web References: Nature Communications, DOI: http://dx.doi.org/10.1038/s41467-025-61903-x
References: Korea Institute of Science and Technology (KIST), KAIST, Seoul National University Hospital, Stanford University
Image Credits: Korea Institute of Science and Technology (KIST)

Keywords

Ultrasound, Silicon, Eco-friendly, Medical Devices, Telemedicine, Healthcare, Innovation, Semiconductor, Nanotechnology, Lead-free, Flexibility, Imaging

One of the standout features of this research is its strong emphasis on sustainability. The use of chitosan, a biopolymer derived from chitin found in crustacean shells, showcases how renewable resources can be applied effectively in modern science. Chitosan’s biocompatibility and biodegradability make it an ideal candidate for drug delivery systems. The use of natural components minimizes environmental impact while promoting efficiency in drug administration. This eco-conscious approach allows for innovative solutions to current medical challenges.

The study specifically investigates the triple-action biological activities of Calligonum comosum extract. This perennial shrub has been utilized in traditional medicine for various ailments, with its rich phytochemical profile suggesting numerous therapeutic properties. The research team aimed to leverage these benefits through a chitosan nanocarrier system designed to enhance the extract’s bioavailability, stability, and controlled release. By encapsulating the extract in nanocarriers, the researchers hope to optimize its therapeutic effectiveness while minimizing side effects commonly associated with conventional drug formulation and delivery.

A further exploration into the pharmacological effects of this nanocarrier system demonstrates how it can combat various pathological conditions. The preliminary findings indicate that the bioactive compounds extracted from Calligonum comosum exhibit significant antioxidant, anti-inflammatory, and antimicrobial properties. These attributes are crucial not only for treating ailments linked to oxidative stress but also for preventing microbial infections that pose a risk in diverse medical contexts. In this regard, the nanocarrier approach may serve as a comprehensive solution, targeting multiple health issues simultaneously with a single formulation.

Moreover, the research method incorporated rigorous experimental paradigms, including in vitro and in vivo studies, which provided a robust understanding of the extract’s efficacy. The researchers meticulously evaluated the cytotoxicity and therapeutic index of the chitosan-loaded nanocarriers, ensuring they produced a beneficial effect without damaging healthy cells. This attention to detail reinforces the credibility of the findings, indicating a promising future for the application of similar systems in therapeutic settings.

As the pharmaceutical industry increasingly pivots towards more holistic treatment methodologies, the implications of this study extend far beyond mere academic curiosity. The chitosan nanocarriers could serve as a blueprint for future drug delivery systems aimed at enhancing the therapeutic index of various herbal extracts. Such innovative systems hold the potential not just to optimize existing treatments but also to pave the way for new ones, making natural medicine a prominent player in modern healthcare.

An exciting aspect of this research is its contribution to the field of nutraceuticals. As consumers increasingly seek plant-based alternatives to synthetic medications, the chitosan nanocarrier system can provide an essential link between ancient herbal knowledge and contemporary medical needs. By validating the efficacy of traditional medicinal plants through modern scientific techniques, this research fosters a greater acceptance of herbal remedies in mainstream healthcare practices.

Furthermore, the collaboration encapsulated in this study highlights the interdisciplinary nature of contemporary biomedical research. The fusion of expertise in pharmacognosy, nanotechnology, and environmental science demonstrates how collective innovation can lead to groundbreaking advancements. Working in tandem, experts can explore the intersections of their fields, ultimately enhancing the impact of scientific inquiry on global health challenges.

Challenges remain, however, as researchers confront various regulatory hurdles in translating their laboratory findings into commercially viable products. The pathway from bench to bedside is often fraught with complexities, including the need for comprehensive safety assessments and compliance with stringent pharmaceutical guidelines. Despite these obstacles, the foundational knowledge derived from studies like this provides a substantial basis for addressing regulatory concerns.

Public interest in natural remedies continues to rise, yet education around their efficacy and safety must keep pace. The dissemination of findings from studies such as that of Khedr et al. plays a pivotal role in informing consumers and healthcare professionals alike about the scientific underpinnings of herbal medicine. Bridging this knowledge gap is crucial in encouraging informed decisions, ultimately leading to wider acceptance of integrated healthcare solutions.

Looking ahead, the potential applications of chitosan nanocarriers are vast. Whether for chronic disease management or acute infection control, the incorporation of natural extracts into modern drug delivery systems could transform patient care landscapes. Researchers are excited about the prospect of tailoring these systems for specific therapeutic needs, thereby increasing treatment outcomes and enhancing patient quality of life.

In conclusion, the innovative research highlighted by Khedr and colleagues exemplifies how blending tradition with cutting-edge science can lead to expansive medical advancements. The eco-friendly approach utilizing chitosan nanocarriers loaded with Calligonum comosum extract illustrates the potential advantages of integrating sustainable practices within healthcare. As studies in this realm progress, the transformative power of nature-inspired medicine could redefine therapeutic paradigms and establish new avenues for treatment.

While further research and development are necessary to fully explore the capabilities of such systems, the outcomes suggest a paradigm shift towards an integrated approach in pharmacotherapy. It focuses not just on efficacy and safety but also on sustainability and responsible resource utilization. The implications of this work could extend far beyond individual health, potentially impacting public health on a global scale through increased accessibility to safe and effective natural remedies.

Subject of Research: Chitosan Nanocarriers and Calligonum comosum Extract

Article Title: Chitosan nanocarriers loaded with Egyptian Calligonum comosum L’Hér. Extract: an eco-friendly approach for investigating triple-action biological activities.

Article References:

Khedr, Y.I., Toto, S.M., El-Darier, S.M. et al. Chitosan nanocarriers loaded with Egyptian Calligonum comosum L’Hér. Extract: an eco-friendly approach for investigating triple-action biological activities. BMC Complement Med Ther 25, 332 (2025). https://doi.org/10.1186/s12906-025-05047-x

Image Credits: AI Generated

DOI: 10.1186/s12906-025-05047-x

Keywords: Chitosan, Calligonum comosum, Nanocarriers, Eco-friendly, Bioactive Compounds, Drug Delivery, Herbal Medicine, Pharmacology, Sustainable Medicine.

Fundamentally, the principle behind this biosensing method lies in the "coffee-ring effect," a commonplace occurrence familiar to anyone who has ever spilled a drop of coffee that later dries into an unmistakable ring-shaped residue. This physical effect results from fluid flow dynamics where suspended particles are transported and deposited unevenly during evaporation. The research team capitalizes on this tendency by engineering plasmonic nanoparticles to concentrate selectively along the drying droplet’s periphery, thus amplifying local electromagnetic fields and significantly enhancing signal detection capabilities.

Plasmonics, the science of harnessing electron oscillations at metallic nanostructure surfaces, plays a pivotal role here. When light interacts with these nanostructures, it induces collective electron oscillations, or surface plasmons, which generate intense localized electromagnetic fields. These enhanced fields dramatically improve the sensitivity of a myriad of optical sensing techniques — such as surface-enhanced Raman scattering (SERS) — enabling the detection of biomolecules present at ultra-low concentrations.

The researchers strategically dispersed plasmonic nanoparticles within the analyte-laden fluid droplet. Upon drying on hydrophilic substrates, the particles spontaneously self-assembled along the droplet’s boundary, forming highly uniform, reproducible plasmonic rings. These rings act as hot spots, significantly boosting optical signals from biological markers attached to the nanoparticle surfaces. The result is a robust biosensing interface capable of revealing subtle biochemical alterations indicative of various pathologies.

Crucially, to interpret the complex optical signals generated by the plasmonic coffee-ring structures, the team employed sophisticated AI algorithms. By integrating machine learning models with biosensor outputs, they achieved real-time classification and quantification of biomarkers, overcoming inherent variations in sample composition, environmental noise, and instrumental factors. This AI-assisted interpretation lends the system unparalleled accuracy and robustness, vital for reliable point-of-care applications.

This research delineates a seamless workflow wherein patient samples—such as blood, saliva, or urine—require only a minute volume for testing. Upon depositing the sample onto the sensor platform and allowing the droplet to dry, operators need only to perform optical interrogation via compact portable devices. Subsequently, embedded AI models decipher the biosensing signals, outputting diagnostic results within minutes, a remarkable improvement over conventional multi-step laboratory assays prone to delays.

The implications of this platform extend beyond mere speed and sensitivity. The fabrication process for the sensor substrates is inexpensive and scalable, relying on readily available materials and straightforward chemical synthesis routes for the plasmonic nanoparticles. This cost-effective design underscores the potential for widespread deployment in resource-limited settings, remote areas, or emergency scenarios where rapid, decentralized diagnostic capability is critically needed.

Delving into the technical specifics of materials, the team employed gold and silver nanoparticles with tailored morphologies tuned to optimize plasmonic resonances in the visible spectrum. Rigorous characterization using electron microscopy, spectroscopy, and computational electromagnetic simulations ensured the reproducibility and efficiency of nanoparticle assembly within the coffee-ring patterns. This meticulous nanoparticle engineering is vital for achieving uniform signal enhancement across batches.

Furthermore, the study addresses challenges frequently encountered with biosensors, such as nonspecific binding and signal variability. By functionalizing the nanoparticle surfaces with selective bioreceptors—such as antibodies or aptamers—they ensured targeted analyte capture with minimal background interference. The AI algorithms were further trained to filter out residual noise and distinguish genuine biomarker signals, enhancing diagnostic confidence.

One of the most compelling aspects of this work is its adaptable nature. Although the current demonstration focuses on detecting protein biomarkers linked to infectious diseases and cancer, the underlying platform is adaptable to a broad spectrum of biological targets. Modifying surface chemistries can customize the biosensor for nucleic acids, metabolites, or environmental toxins, heralding a new class of versatile, multiplexed diagnostic tools.

The integration of AI transforms conventional biosensing into a smart diagnostic system. The authors engineered the software pipeline to learn continuously from accumulated data, improving predictive accuracy as more samples are processed. This adaptive learning framework embodies the concept of continual improvement, potentially enabling personalized diagnostic thresholds tuned to patient populations or even individual physiological variability.

Beyond diagnostics, this plasmonic coffee-ring platform offers exciting prospects for fundamental biomedical research. Its high sensitivity and spatial resolution might enable detecting transient molecular interactions or monitoring dynamic cellular responses in real time. This would pave the way for novel investigative methodologies, spanning from drug discovery to systems biology studies.

Importantly, the researchers conducted extensive validation studies benchmarking their device against gold-standard clinical assays. The results demonstrated impressive concordance, indicating that this point-of-care sensor could reliably approximate laboratory-based diagnostics. This level of validation is paramount to fostering clinician trust and facilitating eventual clinical adoption.

The study also explored the user-interface considerations essential for practical deployment. By combining the sensor with smartphone-based optical readers and intuitive applications, the system empowers non-specialist users to perform diagnostics with minimal training. This democratization of testing aligns with global health priorities emphasizing accessibility and patient autonomy.

Looking ahead, the team envisions leveraging advances in nanophotonics, microfluidics, and expanded AI capabilities to further miniaturize and automate the platform. Incorporating multiplexed detection channels could transform a single assay into a comprehensive health monitoring panel. Moreover, coupling biosensing with wireless data transmission enables integration into telemedicine networks, amplifying its societal impact.

In summary, this pioneering work on plasmonic coffee-ring biosensing combined with AI-driven analysis epitomizes the convergence of physics, nanotechnology, and data science to provide scalable, rapid, and accurate diagnostics. By transforming a deceptively simple natural phenomenon into a sophisticated biosensing tool, this technology heralds a new era of point-of-care healthcare innovation poised to improve outcomes worldwide.

Subject of Research: Development of a plasmonic coffee-ring biosensing platform integrated with AI for enhanced point-of-care diagnostics.

Article Title: Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics.

Article References:
Behrouzi, K., Khodabakhshi Fard, Z., Chen, CM. et al. Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics. Nat Commun 16, 4597 (2025). https://doi.org/10.1038/s41467-025-59868-y

Image Credits: AI Generated

Core-shell nanoparticles are engineered structures with two distinct layers: a core that encapsulates drugs and a shell that serves various functional purposes, including protecting drugs from degradation. This intricate design is pivotal for ensuring that therapeutics remain stable until they reach their desired target. By leveraging the unique properties of materials—ranging from polymers and lipids to inorganic compounds—researchers can tailor these nanoparticles for optimal drug loading and distribution, addressing the specific needs of diverse therapeutic interventions.

One of the paramount benefits of core-shell nanoparticles lies in their capability for controlled drug release. This mechanism not only enhances the efficacy of the treatment but also significantly minimizes adverse effects, rendering it an attractive alternative to traditional drug delivery methods. Enhanced bioavailability and targeted action are essential components of personalized medicine, where treatments are customized based on individual patient profiles. This targeted approach embodies the future of medicine, complementing advancements in genomics and biotechnology that aim to provide precision healthcare solutions.

The study conducted by Suren A. Ramadhan and Diyar S. Ali representatives from Knowledge University and Salahaddin University in Iraq sheds light on several avenues through which core-shell nanoparticles can be utilized effectively. For instance, the ability of these nanoparticles to encapsulate a wide range of therapeutic agents—including chemotherapeutics, biologics, and vaccines—opens up possibilities for developing multifaceted treatment regimens. Moreover, as the healthcare community strives to improve patient outcomes, the role of customized drug delivery systems becomes undeniably significant.

Equipped with the capacity to shield drugs from premature degradation, core-shell nanoparticles foster controlled drug release, enabling the sustained delivery of therapeutics over extended periods. This sustained mechanism is especially crucial for conditions that require chronic treatment, allowing for consistent therapeutic levels while mitigating fluctuations in drug concentration that are common with conventional delivery methods. As such, patients can experience improved treatment outcomes, ultimately leading to a better quality of life.

Current research highlights diverse applications of core-shell nanoparticles in oncology, where they have shown promise in enhancing the effectiveness of chemotherapeutic agents while concurrently reducing their toxic side effects. By utilizing these advanced nanocarriers, clinicians can potentially increase drug efficacy while sparing healthy tissues, a significant advancement in cancer treatment paradigms. This integration of nanotechnology within oncology also points to a future where combination therapies, conducted simultaneously, can be more efficient and targeted.

The development of core-shell nanoparticles also raises questions related to material safety, biocompatibility, and potential toxicity. Researchers are dedicated to addressing these concerns to improve the overall efficacy and safety profile of these nanoparticle systems. This comprehensive investigation enables teams to devise innovative materials that not only deliver drugs effectively but also conform to stringent safety standards. Businesses and research institutions are actively collaborating to generate comparative studies assessing the performance of various core-shell configurations, thereby refining the design process.

As scientists and researchers delve deeper into the potential of nanoparticles, advancements in synthesis techniques promise to yield more sophisticated structures with improved functionalities. Novel approaches, including the use of smart materials responsive to specific triggers—such as pH changes or specific enzymes—can facilitate the design of more intelligent drug delivery systems. This capability could potentially diminish the risk of systemic toxicity while enhancing the therapeutic outcomes for patients who require complex drug regimens.

In conclusion, the meticulous exploration of core-shell nanoparticles is set to redefine therapeutic paradigms in personalized and precision medicine. Their ability to provide targeted, controlled, and sustained drug release represents a paradigm shift that holds the possibility of revolutionizing the way we approach various medical conditions. Such innovations highlight the confluence of nanotechnology and medicine, illustrating a promising trajectory toward more refined healthcare solutions that prioritize patient outcomes. The research community’s dedication to unraveling the complexities of these systems paves the way for groundbreaking advancements that could enhance treatment accessibility, efficacy, and safety.

As we venture forward, the publication of pivotal studies in respected journals is essential to communicate these findings and foster collaborative efforts across the scientific community. The journey of core-shell nanoparticle research exemplifies the innovative spirit that drives science toward a future where healthcare is more personalized, effective, and holistic than ever before.

Subject of Research: Not applicable
Article Title: Innovations in Core–Shell Nanoparticles: Advancing Drug Delivery Solutions and Precision Medicine
News Publication Date: Not applicable
Web References: Not applicable
References: Not applicable
Image Credits: Mary Ann Liebert, Inc.